Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
38 hedge funds and large institutions have $35.7M invested in Alimera Sciences in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 7 closing their positions.
3% less funds holding
Funds holding: 39 → 38 (-1)
10% less capital invested
Capital invested by funds: $39.6M → $35.7M (-$3.9M)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.09M |
| 2 |
JAM
JW Asset Management
Miami Beach,
Florida
|
+$186K |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$143K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$119K |
| 5 |
Renaissance Technologies
New York
|
+$95.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.42M |
| 2 |
DM
Deerfield Management
New York
|
-$1.58M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$467K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$335K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$329K |
ALIM Hedge Fund Activity: Q2 2017 in Review
38 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2017, worth a combined $35.7M — down 9.9% from $39.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ALIM and 6 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 7 added.
The largest buyer was Armistice Capital, adding an estimated $2.09M. The largest seller was Stonepine Capital Management, cutting an estimated $3.42M.
- 38 institutional investors held Alimera Sciences (ALIM) as of Q2 2017, down from 39 in Q1 2017.
- Funds reported $35.7M of Alimera Sciences stock for Q2 2017, down 9.9% quarter-over-quarter.
- 6 funds opened new Alimera Sciences positions in Q2 2017 and 7 closed out, a net change of -1 holder.
- The largest Alimera Sciences buyer in Q2 2017 was Armistice Capital, an estimated $2.09M added.
- The largest Alimera Sciences seller in Q2 2017 was Stonepine Capital Management, an estimated $3.42M sold.
Based on aggregated 13F filings for Q2 2017.